Qiagen releases transcript of Q2 2026 results call

Qiagen published its Q2 2026 results call transcript, hosted by the VP of investor relations with the CEO and CFO participating.

• Q2 net sales were USD 535 million, flat reported and at constant exchange rates, beating guidance for an about 2% CER decline.
• Adjusted diluted EPS was USD 0.62 at CER, above the outlook of at least USD 0.6.
• Full-year guidance was reaffirmed for about 1%-2% CER net sales growth and adjusted diluted EPS of at least USD 2.43 at CER.
• Second-half growth is expected to improve to about 3%-4% at CER, aided by lapping discontinued portfolios and new product launches.